By Dr Katinka Van De Ven

Journal articles

van de Ven K; Malouff J; McVeigh J, 2024, 'The Association Between the Nonmedical use of Anabolic–Androgenic Steroids and Interpersonal Violence: A Meta-Analysis', Trauma, Violence, and Abuse, 25, pp. 1484 - 1495, http://dx.doi.org/10.1177/15248380231186150

van de Ven K; Deane FP; Kelly PJ; Larance B; Beck AK, 2024, 'Online SMART Recovery mutual-help groups: a comparison of the characteristics and experiences of men living in rural and urban regions of Australia', Rural and Remote Health, 24, http://dx.doi.org/10.22605/RRH8861

van de Ven K; Fomiatti R, 2024, 'Problematising anabolic-androgenic steroids in Australian media: Violence, crime and disordered masculinity', Crime, Media, Culture, http://dx.doi.org/10.1177/17416590241281712

Piatkowski T; Havnes IA; Kill E; Ven KVD, 2024, 'Could testosterone be the new methadone? New ways for approaching anabolic-androgenic steroid dependence', Performance Enhancement & Health, 12, pp. 100275 - 100275, http://dx.doi.org/10.1016/j.peh.2024.100275

De Zeeuw TI; Brunt TM; Van Amsterdam J; Van De Ven K; Van Den Brink W, 2023, 'Anabolic Androgenic Steroid Use Patterns and Steroid Use Disorders in a Sample of Male Gym Visitors', European Addiction Research, 29, pp. 99 - 108, http://dx.doi.org/10.1159/000528256

Walsh A; Van de Ven K, 2023, 'Human enhancement drugs and Armed Forces: an overview of some key ethical considerations of creating ‘Super-Soldiers’', Monash Bioethics Review, 41, pp. 22 - 36, http://dx.doi.org/10.1007/s40592-022-00170-8

van de Ven K; Zahnow R; Livingston M, 2023, 'Australian police detainees who use anabolic-androgenic steroids (AAS) and their involvement in violent crimes compared to detainees using substances other than AAS', Performance Enhancement and Health, 11, http://dx.doi.org/10.1016/j.peh.2022.100242

Van De Ven K; Kayser B; Claussen MC; Iff S, 2022, 'Substance use in elite and recreational sport A socio-cultural, medical, and regulatory field of tension', Sports Psychiatry, 1, pp. 131 - 133, http://dx.doi.org/10.1024/2674-0052/a000030

Ritter A; van de Ven K; Vuong T; Chalmers J; Dobbins T; Livingston M; Berends L, 2022, 'Are market mechanisms associated with alcohol and other drug treatment outcomes?', Addiction, 117, pp. 1105 - 1116, http://dx.doi.org/10.1111/add.15681

van de Ven K; Boardley I; Chandler M, 2022, 'Identifying best-practice amongst health professionals who work with people using image and performance enhancing drugs (IPEDs) through participatory action research', Qualitative Research in Sport, Exercise and Health, 14, pp. 199 - 215, http://dx.doi.org/10.1080/2159676X.2021.1898457

Hope VD; Underwood M; Mulrooney K; Mazanov J; van de Ven K; McVeigh J, 2021, 'Human enhancement drugs: Emerging issues and responses', International Journal of Drug Policy, 95, http://dx.doi.org/10.1016/j.drugpo.2021.103459

Atkinson AM; van de Ven K; Cunningham M; de Zeeuw T; Hibbert E; Forlini C; Barkoukis V; Sumnall HR, 2021, 'Performance and image enhancing drug interventions aimed at increasing knowledge among healthcare professionals (HCP): reflections on the implementation of the Dopinglinkki e-module in Europe and Australia in the HCP workforce', International Journal of Drug Policy, 95, http://dx.doi.org/10.1016/j.drugpo.2021.103141

Underwood M; van de Ven K; Dunn M, 2021, 'Testing the boundaries: Self-medicated testosterone replacement and why it is practised', International Journal of Drug Policy, 95, http://dx.doi.org/10.1016/j.drugpo.2020.103087

Dunn M; Mulrooney KJ; Forlini C; van de Ven K; Underwood M, 2021, 'The pharmaceuticalisation of ‘healthy’ ageing: Testosterone enhancement for longevity', International Journal of Drug Policy, 95, http://dx.doi.org/10.1016/j.drugpo.2021.103159

Zoob Carter BN; Boardley ID; van de Ven K, 2021, 'The Impact of the COVID-19 Pandemic on Male Strength Athletes Who Use Non-prescribed Anabolic-Androgenic Steroids', Frontiers in Psychiatry, 12, http://dx.doi.org/10.3389/fpsyt.2021.636706

van de Ven K; Ritter A; Vuong T; Livingston M; Berends L; Chalmers J; Dobbins T, 2021, 'A comparison of structural features and vulnerability between government and nongovernment alcohol and other drug (AOD) treatment providers', Journal of Substance Abuse Treatment, 132, pp. 108467, http://dx.doi.org/10.1016/j.jsat.2021.108467

Thomas N; van de Ven K; Mulrooney KJD, 2020, 'The impact of rurality on opioid-related harms: A systematic review of qualitative research', International Journal of Drug Policy, 85, http://dx.doi.org/10.1016/j.drugpo.2019.11.015

van de Ven K; Dunn M; Mulrooney K, 2020, 'Performance and image enhancing drug (PIED) producers and suppliers: a retrospective content analysis of PIED-provider cases in Australia from 2010-2016', Trends in Organized Crime, 23, pp. 143 - 153, http://dx.doi.org/10.1007/s12117-018-9348-5

van de Ven K; Zahnow R; McVeigh J; Winstock A, 2020, 'The modes of administration of anabolic-androgenic steroid (AAS) users: are non-injecting people who use steroids overlooked?', Drugs: Education, Prevention and Policy, 27, pp. 131 - 135, http://dx.doi.org/10.1080/09687637.2019.1608910

van de Ven K; Dunn M; Mulrooney K, 2020, 'Human enhancement drugs and new(?) research directions', Performance Enhancement and Health, 7, http://dx.doi.org/10.1016/j.peh.2020.100160

van de Ven K; Ritter A; Berends L; Chalmers J; Lancaster K, 2020, 'Perceptions of purchasing and payment mechanisms in alcohol and other drug treatment services in Australia: A qualitative study involving alcohol and other drug service providers and purchasers of treatment', Drug and Alcohol Review, 39, pp. 189 - 197, http://dx.doi.org/10.1111/dar.13027

van de Ven K; Ritter A; Roche A, 2020, 'Alcohol and other drug (AOD) staffing and their workplace: examining the relationship between clinician and organisational workforce characteristics and treatment outcomes in the AOD field', Drugs: Education, Prevention and Policy, 27, pp. 1 - 14, http://dx.doi.org/10.1080/09687637.2019.1622649

Kiepek N; Van de Ven K; Dunn M; Forlini C, 2019, 'Seeking legitimacy for broad understandings of substance use', International Journal of Drug Policy, 73, pp. 58 - 63, http://dx.doi.org/10.1016/j.drugpo.2019.07.014

Belackova V; Roubalova (Stefunkova) M; van de Ven K, 2019, 'Overview of “home” cultivation policies and the case for community-based cannabis supply', International Journal of Drug Policy, 71, pp. 36 - 46, http://dx.doi.org/10.1016/j.drugpo.2019.05.021

, 2019, 'Human Enhancement Drugs', , http://dx.doi.org/10.4324/9781315148328

Mulrooney KJD; van de Ven K; McVeigh J; Collins R, 2019, 'Commentary: Steroid Madness- has the dark side of anabolic-androgenic steroids (AAS) been over-stated?', Performance Enhancement and Health, 6, pp. 98 - 102, http://dx.doi.org/10.1016/j.peh.2019.03.001

Dunn M; McKay FH; van de Ven K, 2019, 'There's a (drug policy) storm coming', Performance Enhancement and Health, 6, pp. 95 - 97, http://dx.doi.org/10.1016/j.peh.2019.05.001

Corazza O; Simonato P; Demetrovics Z; Mooney R; van de Ven K; Roman-Urrestarazu A; Rácmolnár L; De Luca I; Cinosi E; Santacroce R; Marini M; Wellsted D; Sullivan K; Bersani G; Martinotti G, 2019, 'The emergence of Exercise Addiction, Body Dysmorphic Disorder, and other image-related psychopathological correlates in fitness settings: A cross sectional study', PLoS ONE, 14, pp. e0213060, http://dx.doi.org/10.1371/journal.pone.0213060

Ritter A; van de Ven K, 2019, 'Alcohol and other drug treatment commissioning and purchasing: Is it health care or social-welfare?', Drug and Alcohol Review, 38, pp. 119 - 122, http://dx.doi.org/10.1111/dar.12871

Ritter A; van de Ven K, 2019, 'Is health or social welfare the right question? Response to commentaries', Drug and Alcohol Review, 38, pp. 129 - 130, http://dx.doi.org/10.1111/dar.12900

Coomber R; Moyle L; Belackova V; Decorte T; Hakkarainen P; Hathaway A; Laidler KJ; Lenton S; Murphy S; Scott J; Stefunkova M; van de Ven K; Vlaemynck M; Werse B, 2018, 'The burgeoning recognition and accommodation of the social supply of drugs in international criminal justice systems: An eleven-nation comparative overview', International Journal of Drug Policy, 58, pp. 93 - 103, http://dx.doi.org/10.1016/j.drugpo.2018.05.010

van de Ven K, 2018, 'Welcome message from the new Editor-in-Chief', Performance Enhancement and Health, 6, pp. 43 - 43, http://dx.doi.org/10.1016/j.peh.2018.08.001

Van de Ven K; Maher L; Wand H; Memedovic S; Jackson E; Iversen J, 2018, 'Health risk and health seeking behaviours among people who inject performance and image enhancing drugs who access needle syringe programs in Australia', Drug and Alcohol Review, 37, pp. 837 - 846, http://dx.doi.org/10.1111/dar.12831

Henning A; van de Ven K, 2017, '‘Counting your steps’: The use of wearable technology to promote employees’ health and wellbeing', Performance Enhancement and Health, 5, pp. 123 - 124, http://dx.doi.org/10.1016/j.peh.2017.11.002

van de Ven K; Koenraadt R, 2017, 'Exploring the relationship between online buyers and sellers of image and performance enhancing drugs (IPEDs): Quality issues, trust and self-regulation', International Journal of Drug Policy, 50, pp. 48 - 55, http://dx.doi.org/10.1016/j.drugpo.2017.09.004

Koenraadt R; Van de Ven K, 2017, 'The Internet and lifestyle drugs: an analysis of demographic characteristics, methods, and motives of online purchasers of illicit lifestyle drugs in the Netherlands.', Drugs: Education, Prevention, and Policy, pp. 1 - 11, http://dx.doi.org/10.1080/09687637.2017.1369936

van de Ven K; Mulrooney KJD, 2017, 'Social suppliers: Exploring the cultural contours of the performance and image enhancing drug (PIED) market among bodybuilders in the Netherlands and Belgium', International Journal of Drug Policy, 40, pp. 6 - 15, http://dx.doi.org/10.1016/j.drugpo.2016.07.009

van de Ven K, 2016, '‘Blurred lines’: Anti-doping, national policies, and the performance and image enhancing drug (PIED) market in Belgium and The Netherlands', Performance Enhancement and Health, 4, pp. 94 - 102, http://dx.doi.org/10.1016/j.peh.2016.03.003

van de Ven K, 2016, 'Markten, cultuur en prestatie- en uiterlijkbevorderende middelen (PUBM): de eigenschappen van dealers die opereren in België en Nederland', Tijdschrift over Cultuur & Criminaliteit, 6, pp. 26 - 46, http://dx.doi.org/10.5553/tcc/221195072016006002002

Fincoeur B; van de Ven K; Mulrooney KJD, 2015, 'The symbiotic evolution of anti-doping and supply chains of doping substances: how criminal networks may benefit from anti-doping policy', Trends in Organized Crime, 18, pp. 229 - 250, http://dx.doi.org/10.1007/s12117-014-9235-7

Mulrooney KJD; van de Ven K, 2014, 'Blurred lines: The convolution of anti-doping in sport and national policies towards the use of performance and image enhancing drugs', Performance Enhancement & Health, 3, pp. 117 - 117, http://dx.doi.org/10.1016/j.peh.2015.06.033

Mulrooney K; van de Ven K, ''Muscle Profiling': Anti-Doping Policy and Deviant Leisure', SSRN Electronic Journal, http://dx.doi.org/10.2139/ssrn.2581573

Back to profile page